The fact
This decision aims to improve access to these treatments for patients suffering from obesity and its health complications.
Reimbursement represents a major advance in the therapeutic management of obesity in France.
2 sources — click a link to read an article on the topic:
Story timeline
May 28Anti-obesity medications: Wegovy and Mounjaro set to be reimbursedthis article